key: cord-0743496-sj587pxe
authors: Carrillo-Larco, Rodrigo M.
title: COVID-19 data sources in Latin America and the Caribbean
date: 2020-05-29
journal: Travel Med Infect Dis
DOI: 10.1016/j.tmaid.2020.101750
sha: 47fb64a899b32e425bd62fa15ef209cb0f0ef3a6
doc_id: 743496
cord_uid: sj587pxe

nan

The COVID-19 pandemic has affected Latin America and the Caribbean (LAC), 1 where due to lack of resources, some countries are facing difficulties to implement screening/testing strategies for large populations, or to provide care for severe cases (e.g., mechanical ventilation). Under these circumstances, data are paramount for governments to make informed decisions; for academics to conduct research and modelling studies; and for the general public to learn about the local/global progression of the pandemic.

Understanding the global need for data, international organizations and academic institutions provide daily numbers of COVID-19 cases, recoveries and deaths. 2 However, data with greater details are needed to better understand the local/regional profile of the pandemic, not to mention the clinical profile of the cases and deceased. Because global endeavours cannot report all these data, local authorities should make efforts to report as much data as possible (meeting legal, ethical and deidentification standards). This way, independent researcher can (re-)analyse these data and provide outputs relevant for stakeholders and lay people. Moreover, researchers can start regional collaborations to enhance their skills and knowledge, and to pool data to increase statistical power and reduce uncertainty. Research at the regional level can inform and advance the COVID-19 evidence benefiting populations beyond borders; also, this can provide evidence for regional organizations (e.g., Pan-American Health Organizations) to make recommendations as countries in LAC implement strategies of social distancing, and to avoid a second wave once these strategies are over.

Because LAC has not had a strong data pooling history, 3 and the first barrier to use data from multiple sources is knowing where these data are, this letter provides a list of official data sources for 31 countries and territories in LAC (Table) . This work aims to inform the LAC clinical and scientific community about official data sources with greater granularity so that regional research can start.

This list assumes that these government-based data sources reflect truthful, accurate and current information, which may not be the case for several reasons. First, logistic and human resources may not be available to update these data daily; second, the country capacity to identify potential patients, test, and report results may be limited thus affecting data availability; third, although speculative, governments may not want to report all available information transparently.

Some countries provide visualizations with numbers/proportions by gender, age and city/region (e.g., Peru). Some countries provide reports summarizing the information (e.g., Argentina), while others allow to download data in spreadsheets (e.g., Brazil, Colombia, Chile and Mexico). This suggests countries are at a different stage of the data transition, understood as how they can collect/collate, organize, distribute, visualize and share data. This opens opportunities for professionals with data training to collaborate with local/regional institutions and governments to enhance data analysis to inform decisions and policies, as a general practice and during the COVID-19 pandemic. 

COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel medicine and infectious disease

An interactive web-based dashboard to track COVID-19 in real time

Addressing NCDs: is it really a global coalition?

At this time, comparisons about mortality rates may not be accurate, because definitions to ascertain mortality due to COVID-19 may not be standard across countries. Websites with a .gob./.gov.X extension were selected (where X is country in Latin America and the Caribbean; e.g., .gob.pe), or those directly linked from government websites. Links were accessed on April 10, 2020. Mexico was grouped in Central American because of geographic proximity.

Travel Medicine and Infectious Disease requires that all authors sign a declaration of conflicting interests. If you have nothing to declare in any of these categories then this should be stated.

A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated.

Signature (a scanned signature is acceptable,